INTRODUCTION
============

The opposing processes of fusion and fission (division) regulate mitochondrial morphology and function ([@B24]; [@B3]; [@B26]). During mitochondrial fission, the dynamin-related GTPase dynamin-related protein 1 (Drp1) is recruited from the cytosol onto the mitochondrial outer membrane, where it assembles into puncta. These puncta consist of oligomeric Drp1 complexes that wrap around and constrict the mitochondrial tubule to mediate fission ([@B15]). This proposed mechanism is analogous to how dynamin pinches off endocytic vesicles at the plasma membrane ([@B19]; [@B8]). Because much of Drp1 resides in the cytosol, key mechanistic issues are how Drp1 is recruited to the mitochondrial surface and what factors influence its assembly.

In mammals, four integral membrane proteins of the mitochondrial outer membrane---mitochondrial fission protein 1 (Fis1), mitochondrial fission factor (Mff), and mitochondrial dynamics proteins of 49 and 51 kDa (MiD49 and MiD51, respectively)---have been proposed to act as receptors that recruit Drp1 to the mitochondrial surface. However, there is much uncertainty concerning the precise role of these candidates and their relationship to each other. Fis1 was the first proposed receptor, based on definitive genetic and biochemical data from the budding yeast *Saccharomyces cere­visiae*. The yeast Drp1 orthologue, Dnm1, requires Fis1 to localize to mitochondria ([@B7]; [@B16]; [@B22]). Fis1 physically interacts with Dnm1 via one of two molecular adaptors, Mdv1 or Caf4 ([@B23]; [@B2]; [@B10]).

In mammals, however, there are no apparent orthologues of Mdv1 or Caf4, and the evidence supporting a role for Fis1 in mitochondrial fission is mixed. Supporting a role in fission, overexpression of Fis1 in mammalian cells promotes fragmentation of mitochondria ([@B25]; [@B20]; [@B27]), and inhibition of Fis1 results in elongation ([@B25]; [@B14]; [@B20]; [@B12]; [@B9]). However, a recent study showed that deletion of the *Fis1* gene from human colorectal carcinoma HCT116 cells does not disrupt mitochondrial morphology or Drp1 recruitment to mitochondria and suggested that mitochondrial defects from *Fis1-*knockdown studies may be due to off-target effects ([@B17]). Mff is the strongest candidate for a Drp1 receptor. Knockdown of *Mff* results in mitochondrial elongation ([@B9]) and reduces the amount of Drp1 recruited to mitochondria ([@B17]).

MiD49 and MiD51 (also called mitochondrial elongation factor 1) have been proposed to be components of the mitochondrial fission machinery ([@B18]), but there is conflicting evidence concerning their mechanism of action. One study showed that a double knockdown results in mitochondrial elongation and reduces recruitment of Drp1 to mitochondria, supporting a role in fission ([@B18]). Paradoxically, overexpression of either MiD49 or MiD51 also causes mitochondrial elongation ([@B18]; [@B28]), and another study showed that knockdown of MiD51 causes mitochondrial fragmentation ([@B28]). These latter observations led to the alternative proposal that MiD51 inhibits mitochondrial fission ([@B28]).

To clarify the role of these candidate Drp1 receptors, we studied their function in mouse embryonic fibroblasts (MEFs). Our results support their role in mitochondrial fission and indicate that each protein is capable of recruiting Drp1 and promoting mitochondrial fission.

RESULTS
=======

Fis1 and Mff can function independently of one another to regulate mitochondrial fission in MEFs
------------------------------------------------------------------------------------------------

Given the disputed role of Fis1 in mitochondrial fission ([@B17]), we sought to directly compare the roles of Fis1 and Mff by generating MEF cell lines with null alleles of Fis1, Mff, or both. These cells are completely deficient for the relevant proteins (Supplemental Figure S1A). Mitochondrial morphology was assessed by immunofluorescence against the mitochondrial marker Tom20 ([Figure 1A](#F1){ref-type="fig"}). Consistent with previous studies using *Mff* knockdown ([@B9]; [@B17]), mitochondria in *Mff*-null cell lines are severely elongated and interconnected. In contrast, mitochondria in *Fis1*-null cell lines have more moderate elongation and interconnection ([Figure 1A](#F1){ref-type="fig"}). We used a morphology scoring assay in which each cell was categorized as having short tubules, long tubules, net-like mitochondria, or collapsed mitochondria. For both mutants, more cells were found to have long or net-like mitochondria relative to wild-type cells ([Figure 1B](#F1){ref-type="fig"}), but the phenotype of *Mff*-null cells is much more pronounced than that of *Fis1*-null cells. Two other independent pairs of wild-type and *Fis1*-null cell lines gave similar results (Supplemental Figure S1B). Of interest, mitochondrial elongation is most severe in the *Fis1/Mff* double mutant and approaches that of *Drp1*-null cells, indicating that the phenotype of Mff loss is substantially enhanced by additional removal of Fis1.

![Mitochondrial elongation in *Fis1*-null, *Mff*-null, and *Fis1/Mff*-null MEFs. (A) Mitochondrial morphology in wild-type and mutant cells. Mitochondria were visualized by immunofluorescence against Tom20. Scale bar, 10 μm. Inset scale bar, 5 μm. (B) Scoring of mitochondrial network morphologies for the indicated cell lines. Each cell was scored into one of four morphological categories. \*\*\**p* \< 0.001, \*\**p* \< 0.005, \**p* \< 0.02. (C) Morphometric analysis. Well-resolved mitochondria (Tom20) in the cell periphery were used for morphometric analysis. Total mitochondrial number and area were measured; the ratio of these two values was plotted as percentage of wild-type. Twenty ROIs from two independent experiments were analyzed. Error bars, SEM. \**p* \< 0.0001. (D) FRAP analysis. For each of the indicated cell lines, the graph shows the fluorescence recovery over 10 s after photobleaching. Fluorescence data were collected every 200 ms postbleach. (E) Endpoint analysis of FRAP data. The fluorescence recovery ± SEM at 10 s postbleaching is shown. For D and E, 20 FRAP trials were averaged. \*\**p* \< 0.001, \**p* \< 0.01. (F, G) *Fis1*-null (F) and *Mff*-null (G) cells were transiently transfected with expression constructs for Fis1, Mff, or an empty control vector. Cells were scored into one of four morphological categories. F, fragmented; \<50, \<50% of mitochondria are long tubules; \>50, \> 50% of mitochondria are long tubules; N, net-like. \*\**p* \< 0.005, \**p* \< 0.05. Statistical testing was performed by combining the F and \<50 classes, which represent cells with mostly short mitochondria. (H) Cells from the indicated cell lines were treated with 50 μM CCCP for 1 h, 100 μM etoposide for 5 h, 1% O~2~ for 24 h, or 0.1% serum for 3 d. Histograms show the percentage of cells with fragmented or mostly short tubular mitochondria. For B, F, G, and H, data are the averages ± SEM from three independent experiments, with 100 cells scored per experiment. All statistical testing was performed with the Student\'s *t* test.](659fig1){#F1}

These observations were confirmed with several independent methods. First, we used morphometric image analysis to evaluate mitochondrial length/interconnectivity. We quantified the number of discrete mitochondria and the total mitochondrial area in the cell periphery, where individual mitochondria can be readily resolved. The ratio of these two values provided a quantitative measure of mitochondrial length/interconnectivity. Significant differences were found among the wild-type cells and each of the mutants ([Figure 1C](#F1){ref-type="fig"}). The phenotypic trend found with this approach agreed well with the manual morphological scoring.

We also used fluorescence recovery after photobleaching (FRAP) to further quantify these differences in mitochondrial morphology. A region of interest (ROI) containing multiple mitochondria with matrix-targeted Cox8-Dendra2 was photobleached, and the recovery of fluorescence over 10 s was monitored. Because of the short recovery time, the fluorescence recovery is dependent on the length and interconnectivity of the photobleached mitochondria, not on mitochondrial fusion. Each of the mutant cell lines demonstrates higher levels of recovery than wild-type cells, with *Fis1/Mff*-null cells having the highest level ([Figure 1, D and E](#F1){ref-type="fig"}, and Supplemental Figure S1C). The recovery properties of *Fis1*-null and *Mff*-null cells were intermediate, with *Mff*-null cells showing higher levels of recovery than *Fis1*-null cells. To corroborate the FRAP results, we used an independent approach to measure the diffusion of Cox8-Dendra2. After photoconverting Cox8-Dendra2 with a 405-nm laser in a region of interest, we quantified the area to which the photoconverted signal immediately spread. We found that *Fis1/Mff*-null cells have the largest diffusion value, followed by *Mff*-null, then *Fis1*-null, and lastly wild-type cells (Supplemental Figure S1D). Taken together, these results demonstrate that both Fis1 and Mff regulate mitochondrial length and interconnectivity, with Mff playing the predominant role in MEFs.

Given that both Fis1 and Mff function to regulate mitochondrial morphology, we tested whether Fis1 and Mff could act independently of one another. When *Fis1*-null and *Mff*-null cells are transfected with Fis1 and Mff expression constructs, respectively, both show a robust rescue in mitochondrial morphology as expected ([Figure 1, F and G](#F1){ref-type="fig"}, and Supplemental Figure S2). Of interest, when Fis1 is expressed in *Mff*-null cells or Mff is expressed in *Fis1*-null cells, there is also a substantial, albeit less complete, rescue in mitochondrial morphology. These results demonstrate that Fis1 and Mff can act independently and partially replace each other to regulate mitochondrial morphology.

Mitochondrial fission is induced by a number of physiological situations ([@B24]; [@B3]). To determine whether Fis1 or Mff might selectively mediate mitochondrial fission in one of these pathways, we challenged wild-type and mutant cells with carbonyl cyanide *m*-chlorophenylhydrozone (CCCP; for mitochondrial membrane depolarization), staurosporine (STS) or etoposide (for apoptosis), 1% O~2~ (for hypoxia), or 0.1% serum ([Figure 1H](#F1){ref-type="fig"} and Supplemental Figure S1E). After each challenge, *Fis1*-null cells show mitochondrial shortening, but less than in wild-type cells. In contrast, *Mff*-null and *Fis1/Mff*-null cell lines are highly resistant to mitochondrial shortening after each of these treatments. We conclude that both Fis1 and Mff are important for mitochondrial fission under basal and induced conditions, with Mff playing a larger role in both cases.

Fis1 and Mff are important for recruitment of Drp1 to mitochondria
------------------------------------------------------------------

To determine whether the mutant cells are defective in recruiting Drp1, we used immunofluorescence to visualize Drp1 puncta on mitochondria in vivo. In wild-type cells, much of the Drp1 staining is diffuse in the cytosol, but a proportion can be found in punctate structures on mitochondria. This recruitment to mitochondria is reduced in cells with *Mff* knockdown ([@B17]). Our knockout cells have reduced numbers of mitochondrial Drp1 puncta, with *Fis1/Mff*-null cells having the greatest defect, followed by *Mff*-null cells and then *Fis1*-null cells ([Figure 2A](#F2){ref-type="fig"}). We used image analysis to quantify the density (number of puncta/mitochondrial area) of Drp1 puncta on mitochondria ([Figure 2B](#F2){ref-type="fig"}). *Fis1*-null cells have a small but significant decrease in the density of mitochondrial Drp1 puncta. *Mff*-null and *Fis1/Mff*-null cells have more substantial decreases. Of interest, the average total fluorescence per puncta ([Figure 2, A and C](#F2){ref-type="fig"}), as well as the average size of puncta (Supplemental Figure S1F), also show substantial declines in the mutant cells. As expected, exogenous expression of Mff in *Mff*-null cells rescued mitochondrial morphology and restored mitochondrial Drp1 puncta (Supplemental Figure S2, B and D). This rescue depended on the R1 region (containing an 11-residue repeat) and the transmembrane domain, as previously shown ([@B9]; [@B17]). The levels of Drp1 in purified mitochondrial fractions from *Mff*-null and *Fis1/Mff*-null cells were substantially lower than those from wild-type and *Fis1*-null cells ([Figure 2D](#F2){ref-type="fig"}). The levels from *Fis1*-null mitochondria were only slightly less than wild-type levels. These imaging and biochemical data indicate that Fis1 and Mff facilitate Drp1 recruitment onto mitochondria, with Mff playing the predominant role.

![Drp1 recruitment and assembly on mitochondria are affected in *Fis1*-null and *Mff*-null cells. (A) Drp1 puncta in the indicated cell lines. To improve visualization of mitochondrial Drp1, the cells were briefly treated with 0.001% digitonin before fixation to reduce the level of cytosolic Drp1. Mitochondria were highlighted by immunofluorescence against Tom20. Scale bar (left), 10 μm. Center and right, magnified images of the boxed regions. Scale bar, 5 μm. Right panel, a mask corresponding to the mitochondrial channel was applied to the Drp1 channel to obtain only mitochondrial Drp1 fluorescence. The heat map reflects Drp1 fluorescence intensity (FI). (B) Density of mitochondrial Drp1 puncta. (C) Drp1 fluorescence per puncta. In B and C, the data are normalized to the wild-type control. Error bars, SEM. Twenty-five ROIs were analyzed from 10 to 12 cells for each group. \**p* \< 0.05, \*\**p* \< 0.005. Statistical testing was performed with the Student\'s *t* test. (D) Drp1 recruitment to mitochondria. Cytosol and purified mitochondrial fractions were prepared from the indicated MEF cells and analyzed by Western blotting for Drp1, Tom20 (mitochondrial marker), and β-tubulin (TUBB; cytosolic marker). The mitochondrial lanes were loaded with 30-fold more cell equivalents than with the cytosolic lanes. Both short and long exposures for the Drp1 blot are presented.](659fig2){#F2}

The MiDs can mediate mitochondrial fission in the absence of Fis1 and Mff
-------------------------------------------------------------------------

MiD49 and MiD51 play important roles in controlling mitochondrial morphology, but it is unclear whether they positively ([@B18]) or negatively regulate mitochondrial fission ([@B28]). One study found that simultaneous knockdown of both *MiD49* and *MiD51* caused mitochondrial elongation ([@B18]), whereas another study found that knockdown of *MiD51* caused mitochondrial fragmentation ([@B28]). To examine this issue, we used short interfering RNA (siRNA) to knock down *MiD49* and *MiD51*. Knockdown of either gene causes a similar enhancement of mitochondrial length and interconnectivity ([Figure 3, A and B](#F3){ref-type="fig"}, and Supplemental Figure S3), suggesting that these proteins positively regulate mitochondrial fission. Simultaneous knockdown of *MiD49* and *MiD51* does not cause a more severe phenotype than knockdown of either gene alone. It was previously reported that knockdown of both genes is necessary to cause mitochondrial elongation ([@B18]). Our observation that a single knockdown is sufficient may be due to a higher efficiency of knockdown. For both *MiD49* and *MiD51*, we identified multiple siRNAs that caused a similar elongation of mitochondria (Supplemental Figure S3 B).

![Knockdown of *MiD49* or *MiD51* causes mitochondrial elongation and enhances the *Fis1*-null, *Mff-*null, and *Fis1/Mff*-null phenotypes. (A) Mitochondrial morphology in wild-type MEFs treated with control siRNA, siRNA against *MiD49*, siRNA against *MiD51*, or both. Scale bar, 10 μm. Insets are magnified images of the boxed regions. Scale bar, 5 μm. Mitochondria were highlighted by expression of Cox8-DsRed. (B) Western blot of cell lysates containing single and double knockdown of the MiDs. SOD2 is a loading control. (C) Scoring of mitochondrial network morphologies for knockdown experiments in wild-type, *Fis1*-null, *Mff*-null, and *Fis1/Mff*-null cells. Data were obtained from three independent experiments, with 100 cells scored per experiment. Error bars, SEM. C, collapsed; L, long; N, net-like; S, short.](659fig3){#F3}

The mitochondrial phenotype of *Fis1/Mff­*-null cells is not as severe as that of *Drp1*-null cells ([Figure 1, A and B](#F1){ref-type="fig"}), suggesting that residual mitochondrial fission exists in these cells. We found that knockdown of either *MiD49* or *MiD51* enhances the mitochondrial connectivity of *Fis1/Mff*-null cells, as well as in *Fis1-*null and *Mff-*null cells ([Figure 3C](#F3){ref-type="fig"} and Supplemental Figure S3B). Simultaneous knockdown of *MiD49* and *MiD51* again does not cause a more severe phenotype than knockdown of either gene alone.

If MiD49 and MiD51 are involved in mitochondrial fission, it is puzzling that overexpression of either protein leads to extreme mitochondrial elongation ([@B18]; [@B28]). We also found similar elongation of mitochondria when MiD49 or MiD51 is overexpressed (see [Figure 5C](#F5){ref-type="fig"} later in the paper). This effect is associated with enhanced Drp1 levels on mitochondria ([Figure 4C](#F4){ref-type="fig"} and Supplemental Figure S4C). We wondered whether these proteins might be recruiting an inactive form of Drp1. Phosphorylation of Drp1 at S637 has been shown to negatively regulate Drp1 function ([@B4]; [@B6]; [@B1]). Drp1 is also phosphorylated at S616, and this modification has been shown to positively regulate Drp1 function during mitosis ([@B21]; [@B11]). Using phosphospecific Drp1 antibodies that detect phosphorylation on S616 or S637, we found that levels of Drp1 S637-PO~4~, but not S616-PO~4~, are significantly enhanced in cell lines constitutively overexpressing either MiD49 or MiD51 ([Figure 4, A and B](#F4){ref-type="fig"}, and Supplemental Figure S4A). We also found enhanced levels of Drp1 S637-PO~4~, but not S616-PO~4~, in the mitochondrial fractions of these cells ([Figure 4C](#F4){ref-type="fig"}, bottom). These results suggest that the MiDs may preferentially bind to the S637-PO~4~ form of Drp1. To test this idea, we cotransfected 293T cells with Myc-tagged forms of MiD49 or MiD51 in combination with wild-type Drp1, an S → A (phospho-null) mutant or an S → D (phosphomimetic) mutant of Drp1 at S616 or S637. Cells were treated with a reversible cross-linker to capture the MiD--Drp1 interaction, and cell lysates were subjected to anti-myc immunoprecipitation. Wild-type Drp1 and Drp1^S637D^ were coimmunoprecipitated more efficiently than Drp1^S637A^ ([Figure 4D](#F4){ref-type="fig"}). This preference is specific for residue S637 and is not found for S616.

![Overexpression of MiD49 or MiD51 causes enhanced phosphorylation of Drp1 on S637. (A) Increased Drp1 S637-PO~4~ in cells overexpressing MiD49 or MiD51. Top, lysates from control HeLa cells or HeLa cells expressing MiD49-Myc or MiD51-Myc were analyzed by Western blotting for Drp1 and the Myc-tagged MiD. Bottom, Drp1 was immunoprecipitated, and the levels of Drp1 S637-PO~4~ were detected with a phosphospecific Drp1 antibody. Drp1 was used as a loading control for the immunoprecipitated samples. (B) Drp1 S616-PO~4~ levels in cells overexpressing MiD49 or MiD51. Lysates from control HeLa cells or HeLa cells expressing MiD49-Myc or MiD51-Myc were analyzed by Western blotting for Drp1, Drp1 S616-PO~4~, and the Myc-tagged MiD. Actin was used as a loading control. (C) Increased Drp1 S637-PO~4~ recruitment to mitochondria in cells overexpressing MiD49 or MiD51. Top, cytosol and crude mitochondrial fractions were prepared from the indicated HeLa cells and analyzed by Western blotting for Drp1, superoxide dismutase 2 (SOD2; mitochondrial), and β-tubulin (TUBB; cytosolic). The mitochondrial lanes were loaded with 20-fold more cell equivalents than with the cytosolic lanes. Bottom, the loading of mitochondrial fractions was normalized for the total Drp1 level. The relative levels of Drp1 S616-PO~4~ and Drp1 S637-PO~4~ on mitochondria were assessed by Western blotting with phosphospecific antibodies. In A--C, densitometry was performed on the S616-PO~4~ and Drp1 S637-PO~4~ blots and was normalized to the total Drp1 in each sample. Values are presented as proportions of wild type. (D) Binding of MiD49 and MiD51 to phospho-mutants of Drp1. 293T cells were cotransfected with Myc-tagged MiD and Drp1 mutants as indicated. Cells were treated with cross-linker and solubilized. Top, expression of Drp1 and Myc-MiD in the lysates. Bottom panel, anti-Myc immunoprecipitates were analyzed for Drp1. Note that this assay only detects transfected Drp1 (compare lanes 2, 3--7, and 10). A, phospho-null mutant; D, phosphomimetic mutant; S, wild-type Drp1.](659fig4){#F4}

![Mitochondrial elongation and increased Drp1 S637-PO~4~ caused by MiD overexpression can be reversed by CCCP. (A) Reduction of Drp1 S637-PO~4~ levels in CCCP treated cells. Left, lysates from control HeLa cells or HeLa cells expressing MiD49-Myc or MiD51-Myc were analyzed by Western blotting for Drp1. Cells were treated with dimethyl sulfoxide (DMSO; indicated by D) or CCCP (indicated by C). Right, Drp1 S637-PO~4~ was analyzed as in [Figure 4A](#F4){ref-type="fig"}. Both short and long exposures for the Drp1 S637-PO~4~ blot are presented. (B) Drp1 S616-PO~4~ levels do not change in CCCP-treated cells. Lysates from control HeLa cells or HeLa cells expressing MiD49-Myc or MiD51-Myc were analyzed as in [Figure 4B](#F4){ref-type="fig"}. Cells were treated with DMSO (indicated by D) or CCCP (indicated by C). Densitometry was performed on the S616-PO~4~ and Drp1 S637-PO~4~ blots and was normalized to the total Drp1 in each lane. Values are presented as ratios of the CCCP/DMSO values for each group. (C) CCCP reverses mitochondrial elongation in MiD-overexpressing MEFs. Cells were transfected with MiD49-Myc or MiD51-Myc and subsequently treated with vehicle (DMSO) or CCCP. MiD-expressing cells were identified by Myc immunofluorescence, and mitochondria were visualized with Tom20 immunofluorescence. In the DMSO-treated samples, note that MiD-Myc expression causes mitochondrial elongation. In the CCCP-treated samples, note that MiD-Myc--expressing cells have fragmented mitochondria. Scale bar, 10 μm. (D) Scoring of mitochondrial network morphologies for MEFs transfected with MiD49-Myc, MiD51-Myc, or empty vector and treated with DMSO or CCCP. The data are from three independent experiments, each with 100 cells scored. Error bars, SEM. C, collapsed; L, long; N, net-like; S, short.](659fig5){#F5}

Dephosphorylation at S637 is activated by CCCP and STS ([@B6]; [@B1]). Treatment of MiD-overexpressing cells with CCCP caused a reduction in Drp1 S637-PO~4~ levels ([Figure 5A](#F5){ref-type="fig"}) and further enhancement of Drp1 recruitment to mitochondria (Supplemental Figure S4C). In contrast, phosphorylation at S616 was not modulated during CCCP treatment in wild-type cells or cells constitutively overexpressing either MiD49 or MiD51 ([Figure 5B](#F5){ref-type="fig"}). Of interest, mitochondria in cells overexpressing MiD49 or MiD51 showed rapid and robust shortening upon treatment with CCCP or STS ([Figure 5, C and D](#F5){ref-type="fig"}, and Supplemental Figure S4B). Thus the mitochondrial elongation caused by MiD overexpression is associated with enhanced Drp1 S637-PO~4~ levels and can be reversed by treatments that cause dephosphorylation of Drp1 at this site.

With a method to activate the pro-fission mode of the MiDs, we investigated whether they are capable of mediating mitochondrial fission in the absence of Fis1 and Mff. Expression of either MiD protein partially rescues recruitment of Drp1 to the mitochondria of *Fis1/Mff*-null cells ([Figure 6, A and B](#F6){ref-type="fig"}). In spite of this Drp1 recruitment, the mitochondria of *Fis1/Mff*-null cells expressing MiDs remain extremely elongated ([Figure 6, A, C, and D](#F6){ref-type="fig"}). As noted earlier, *Fis1/Mff*-null cells are highly resistant to CCCP-induced mitochondrial fragmentation ([Figure 1H](#F1){ref-type="fig"}). However, when these cells overexpress MiD49 or MiD51 and are treated with CCCP, their mitochondria undergo rapid shortening, in contrast to nontransfected cells or cells transfected with an empty vector ([Figure 6, C and D](#F6){ref-type="fig"}). Taken together, our experiments demonstrate that, under certain cellular contexts, the MiDs can function in the absence of Fis1 and Mff to recruit Drp1 to mitochondria and mediate mitochondrial fission.

![MiD49 and MiD51 can restore CCCP-induced mitochondrial fragmentation in *Fis1/Mff*-null cells. (A) Restoration of Drp1 puncta in *Fis1/Mff*-null cells. *Fis1/Mff*-null cells were transfected with MiD49-Myc, MiD51-Myc, or empty vector. Cells were analyzed for MiD-Myc expression (anti-Myc), mitochondrial morphology (Cox8-Dendra2), and Drp1. Scale bar, 10 μm. Right, magnified images of the boxed regions. Scale bar, 5 μm. (B) Density of Drp1 puncta on mitochondria. Twenty ROIs were analyzed in 8--10 cells per group. Data are normalized to wild-type cells. Error bars, SEM. \**p* \< 0.001. DM, *Fis1/Mff* double mutant. (C) Scoring of mitochondrial network morphologies for *Fis1/Mff*-null cells transfected with MiD49-Myc, MiD51-Myc, or empty vector and treated with DMSO or CCCP. Data are from three independent experiments, each with 100 cells scored. Error bars, SEM. C, collapsed; L, long; N, net-like; S, short. \*\**p* = 0.002, \**p* = 0.02. (D) Representative micrographs of *Fis1/Mff*-null cells transfected with MiD49-Myc or MiD51-Myc and treated with DMSO or CCCP. MiD-Myc--expressing cells were analyzed for mitochondrial morphology (Tom20). With CCCP treatment, note that the MiD-Myc--transfected cells have fragmented mitochondria, whereas the nontransfected cells are resistant to CCCP-induced fragmentation. Scale bar, 10 μm. Statistical testing was performed with the Student\'s *t* test.](659fig6){#F6}

DISCUSSION
==========

Our work clarifies several issues concerning the recruitment of Drp1 to mitochondria. Analysis of *Fis1*-null MEFs indicates a clear, although minor, role of Fis1 in Drp1 recruitment and mitochondrial fission. Consistent with previous results ([@B17]), its role appears to be substantially less important than that of Mff. It is possible that the relative importance of Fis1 versus Mff depends on the particular cell type. Cell-type specificity might explain why we found a clear mitochondrial morphology defect in *Fis1*-null MEFs versus a previous study of *Fis1*-null HCT116 cells ([@B17]). It is also possible that the relative importance of these proteins depends on which signaling pathway is activated, although we have not yet identified conditions that selectively promote Fis1-mediated fission ([Figure 1H](#F1){ref-type="fig"}).

Our results suggest that Fis1 and Mff, beyond merely recruiting Drp1, might have a role in promoting Drp1 assembly. In the absence of Fis1, Mff, or both, the remaining Drp1 puncta associated with mitochondria are notably smaller in size and lower in intensity. In this regard, these Drp1 receptors may play a role similar to yeast Mdv1, which promotes self-assembly of Dnm1 ([@B13]). Future biochemical studies are needed to test this model.

Previous studies yielded perplexing observations of MiD49 and MiD51 overexpression versus knockdown. In particular, it was unclear why MiD overexpression causes mitochondrial elongation ([@B18]; [@B28]). We find that when these proteins are overexpressed, recruitment of Drp1 is enhanced, but there is also increased inhibitory phosphorylation of Drp1 on S637. With CCCP treatment, this phosphorylation is reduced, and mitochondrial fission ensues. We cannot rule out that additional mechanisms might also inhibit Drp1 function upon MiD overexpression. Our results suggest the potential for regulation, in which the outcome of MiD activity depends on the physiological state of the cell. For example, we speculate that MiDs might recruit Drp1 but maintain it in an inactive state until a cellular signal triggers fission.

Finally, our results indicate that Fis1, Mff, MiD49, and MiD51 can each recruit Drp1 and promote mitochondrial fission. In particular, the MiDs are able to promote fission in the absence of both Fis1 and Mff. It remains possible that these proteins can also function together to mediate fission. Future studies will clarify whether these proteins preferentially operate in specific cell types or cellular circumstances.

MATERIALS AND METHODS
=====================

Materials
---------

Antibody sources were as follows: Drp1 (BD Biosciences, San Diego, CA), Drp1 S616-PO~4~ and S637-PO~4~ (Cell Signaling Technology, Beverly, MA), superoxide dismutase 2 (SOD2; Abcam, Cambridge, MA), β-tubulin (TUBB; Imgenex, San Diego, CA), Tom20 (Santa Cruz Biotechnology, Santa Cruz, CA), MiD49 (also known as SMCR7; Proteintech Group, Chicago, IL), MiD51 (also known as SMCR7L; Proteintech Group), actin (Millipore, Billerica, MA), Fis1 (Alexis/Axxora, San Diego, CA), Mff (Sigma-Aldrich, St. Louis, MO; and gift from A. van der Bliek, University of California, Los Angeles, Los Angeles, CA), and Myc (mouse monoclonal 9E10 from Covance, Berkeley, CA; and rabbit polyclonal from Sigma-Aldrich). CCCP (Sigma-Aldrich) was used at 50 μM. Staurosporine (Sigma-Aldrich) was used at 1 μM. Etoposide (Sigma-Aldrich) was used at 100 μM. Z-VAD-FMK (BD Biosciences) was used at 50 μM. Cells were grown in LabTek chambered glass slides (Nunc, Rochester, NY) for fixed- and live-cell imaging.

Immunofluorescence and imaging
------------------------------

For immunofluorescence, cells were fixed in 4% formaldehyde for 10 min at 37°C, permeabilized with 0.1% Triton X-100 at room temperature, and incubated with antibodies in 5% fetal calf serum. For Drp1 immunofluorescence, cells were permeabilized in a low-concentration digitonin buffer (0.001% digitonin, 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid \[HEPES\], 150 mM NaCl, 2 mM MgCl~2~, 2 mM EDTA, 320 mM sucrose, pH 7.4) for 1.5 min at 37°C and then immediately fixed. Cells were then processed as described.

Scoring of mitochondrial network morphology was performed blind to genotype and treatment. All quantification was done in triplicate, and 100 cells were scored per experiment.

All fluorescence imaging was performed using a Plan-Apochromat 63×/1.4 oil objective on a Zeiss LSM 710 confocal microscope driven by Zen 2009 software (Carl Zeiss, Jena, Germany). Image cropping was performed using ImageJ software (National Institutes of Health, Bethesda, MD). Global adjustments to brightness and contrast were performed using Photoshop (Adobe, San Jose, CA). We used 488- and 561-nm lasers to excite unconverted and photoconverted Dendra2, respectively, and a 405-nm laser to photoconvert Dendra2. Live-cell imaging was done on a stage-top heated platform maintained at 37°C.

FRAP and diffusion assays
-------------------------

Cells constitutively expressing matrix targeted Cox8-Dendra2 were used for both assays. For FRAP, mitochondria in a 13 × 2 μm region were photobleached using a 405-nm laser at 10% laser power. Imaging was performed in a 15 × 9 μm region. Bleaching was performed to ∼10% of original fluorescence for all trials. For photoconversion of Cox8-Dendra2, a 405-nm laser at 4% laser power was used to photoconvert mitochondria in a 13 × 2 μm region. After photoconversion, a *Z*-stack was collected of the entire cell. The area of the signal was measured using ImageJ and normalized to the original photoconverted area of mitochondria in the 13 × 2 μm region.

Image analysis
--------------

All image analysis was performed using ImageJ software. For mitochondrial morphometric analysis, *Z*-stacks were collected from cells labeled with Tom20, and summed projections were generated. Analysis was limited to regions of interest in the periphery of cells, where individual mitochondria are readily resolved, and images were thresholded to select mitochondria. From the thresholded fluorescence, binary images were generated, and the total mitochondrial area and number of discrete mitochondria were measured. The morphometric ratio was generated by dividing the number of mitochondria by the total mitochondrial area.

Mitochondrial Drp1 puncta were analyzed in the periphery of cells by first creating a binary mask of the mitochondrial channel (Tom20 or Cox8-Dendra2) and using it to subtract all extramitochondrial Drp1 fluorescence. To select mitochondrial Drp1 puncta for analysis, mitochondrial Drp1 fluorescence was thresholded. The thresholding value was determined as the average threshold value needed to select mitochondrial Drp1 puncta in wild-type cells. To count mitochondrial puncta and measure their area, the thresholded image was converted to a binary image. To measure Drp1 puncta fluorescence, puncta identified by thresholding were analyzed for fluorescence intensities.

Generation of mutant MEFs
-------------------------

Mouse embryonic stem (ES) cell lines containing gene trap disruptions of Fis1 (line S9-7D1) and Mff (line AZ0438) were available at the Mutant Mouse Regional Resource Centers. The ES cell lines were injected into blastocysts to generate mouse lines. From matings of heterozygous animals, we established MEF lines from mid­gestation embryos as previously described ([@B5]). Western blot analysis of the *Fis1*-null, *Mff*-null, and *Fis1/Mff*-null cells confirmed complete loss of the relevant proteins (Supplemental Figure S1A).

Cell culture
------------

Cell lines stably expressing Cox8-Dendra2, MiD49-Myc, and MiD51-Myc were generated via retroviral transduction. All cell lines were cultured in DMEM containing 10% fetal bovine serum and supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, and 2 mM glutamine.

For hypoxia experiments, cells were placed into a Billups-Rothenberg modular incubator chamber, and the atmosphere was exchanged with 1% O~2~/5% CO~2~. The O~2~ levels were monitored using a Sperian Toxipro single-gas detector (Honeywell Analytics, Lincolnshire, IL). Cells were incubated at 37°C for 24 h.

Cloning and RNA interference
----------------------------

*Fis1, Mff* isoform 5*, MiD49, MiD51*, and *Drp1* variant 2 transcripts were amplified from a MEF cDNA library using PCR. *MiD49* and *MiD51* were cloned into the *Xho*I and *Bam*HI sites of a pcDNA3.1(--) plasmid containing a C-terminal 4xMyc tag. *Fis1, Fis1ΔTMD* (transmembrane domain deleted), *Mff* isoform 5, *MffΔR1* (amino acid repeat 1 \[residues 20--31\] deleted), *MffΔTMD*, and *Drp1* variant 2 were cloned into the *Bam*HI and *Xho*I sites of pcDNA3.1(+). The entire open reading frames were confirmed by DNA sequencing. For generation of retroviral vectors, MiD49/51-Myc, Mff, MffΔR1, and MffΔTMD sequences were cloned into the pQCXIP-Puromycin vector (Invitrogen, Carlsbad, CA). Cells transduced with these viral constructs were selected with 1 μg/ml puromycin (Invitrogen) for 4--5 d.

Oligonucleotides for siRNAs were purchased from Integrated DNA Technologies (Coralville, IA). The *MiD49* siRNA oligonucleotides were based on the following sequences: 5′-ACACCTAAGTTCAGCACTATAGCAC-3′ (*MiD49*siRNA \#1)5′-GCCATGCCTTGAAGATGTGAATAAA-3′ (*MiD49*siRNA \#2)

The *MiD51* siRNA oligonucleotides were based on the following sequences: 5′-AGATTCCAAATGTCCTAAATCACAG-3′ (*MiD51*siRNA \#1)5′-GGAATAAGACAGTATTTAGGTTTCC-3′ (*MiD51*siRNA \#2)

Results presented in [Figure 3](#F3){ref-type="fig"} were obtained with *MiD49* siRNA \#1 and *MiD51* siRNA \#1. Results presented in Supplemental Figure S3 were obtained with *MiD49* siRNA \#2 and *MiD51* siRNA \#2. Control siRNA was targeted against a noncoding sequence in the mouse genome: 5′-CGTTAATCGCGTATAATACGCGTAT-3′

siRNA nucleotides and plasmids were transfected using Lipofectamine 2000 (Invitrogen). Cells transfected with plasmids were assessed 24 h posttransfection. Fis1 and Mff plasmids were cotransfected with either Cox8-TagRFP or Cox8-DsRed at a ratio of 5:1. MiD49/51-Myc--positive cells were visualized with an anti-Myc antibody. Transfection of siRNA oligonucleotides was performed when cells were plated and at 24 and 48 h postplating. Mitochondrial morphology and protein levels were assessed at 72 h.

Drp1 immunoprecipitation and cell fractionation
-----------------------------------------------

To assess levels of Drp1 S637-PO~4~, we immunoprecipitated Drp1 (anti-DLP1; BD Biosciences) from 5 million cells lysed in IP buffer (1% Triton X-100, 5% glycerol, 150 mM NaCl, 25 mM Tris-HCl, 1 mM EDTA, pH 7.4) supplemented with a protease inhibitor cocktail (HALT; Thermo-Pierce, Rockford, IL). The lysates were cleared with a 21,000 × *g* spin at 4°C for 10 min. Immune complexes were captured with protein A/G agarose (Thermo-Pierce), and the beads were washed with IP buffer.

For cell fractionation, cells were collected by trypsinization and washed once with phosphate-buffered saline (PBS). Cells were resuspended in 1.5 ml of mitochondria isolation buffer (10 mM HEPES, 220 mM mannitol, 70 mM sucrose, 80 mM KCl, 0.5 mM EDTA, 2 mM Mg acetate, pH 7.4) supplemented with a protease inhibitor cocktail and lysed using a nitrogen bomb (Parr, Moline, IL) at 250 psi for 10 min, followed by mechanical homogenization with a glass Dounce homogenizer. Lysates were centrifuged at 700 × *g* three times for 10 min to obtain a postnuclear supernatant. The postnuclear supernatant was centrifuged at 10,000 × *g* for 10 min to obtain a crude mitochondrial pellet. The resultant supernatant was centrifuged at 21,000 × *g* for 30 min to obtain the cytosol fraction. To obtain purified mitochondria, the crude mitochondrial pellet was placed in a discontinuous Percoll gradient consisting of 80, 52, and 26% Percoll diluted in mitochondria isolation buffer. Centrifugation was performed at 42,500 × *g* for 45 min. Purified mitochondria were recovered from the 52 and 26% Percoll interface.

Myc coimmunoprecipitation assay
-------------------------------

MiD-Drp1 interactions were assessed by transfecting 293Ts with Myc-tagged MiD constructs and Drp1 mutant constructs. For mouse Drp1 variant 2, residues S579 and S600 correspond to human Drp1 residues S616 and S637, respectively. Human nomenclature is presented in [Figure 4D](#F4){ref-type="fig"} for consistency. Cells were harvested by trypsinization 24 h posttransfection, and cross-linked with 250 μM dithiobis(succinimidylpropionate) (Thermo-Pierce) in PBS for 30 min at room temperature. Cross-linker was quenched by adding Tris-HCl, pH 7.5, to a final concentration of 150 mM and incubating for an additional 10 min. Cells were pelleted, the quenched cross-linker solution was removed, and pellets were solubilized in RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% SDS, and 1% NP-40) supplemented with a protease inhibitor cocktail. Myc immunoprecipitation was performed with rabbit anti-Myc agarose beads (Sigma-Aldrich). Cross-link bonds were reversed by solubilizing samples in Laemmli buffer (50 mM Tris-HCl, pH 6.8, 1% SDS, 5% glycerol, and 0.005% bromophenol blue) containing 10% β-mercaptoethanol and boiling for 5 min.
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CCCP

:   carbonyl cyanide *m*-chlorophenylhydrozone

DMSO

:   dimethyl sulfoxide

Drp1

:   dynamin-related protein 1

Fis1

:   mitochondrial fission protein 1

FRAP

:   fluorescence recovery after photobleaching

MEF

:   mouse embryonic fibroblast

Mff

:   mitochondrial fission factor

MiD49

:   51, mitochondrial dynamics proteins of 49 and 51 kDa, respectively

ROI

:   region of interest

siRNA

:   short interfering RNA

STS

:   staurosporine
